Q&A

Q&A: Achieving Reagent-Free Blood Analysis With Optical Spectroscopy

Source: ELCAN Optical Technologies

A Q&A with Olga Pawluczyk, President and CEO, P&P Optica

P&P Optica Inc. (Waterloo, ON, Canada) burst onto the optical spectroscopy scene earlier this year after receiving a major technology development award from the Canadian government. Olga Pawluczyk, president of P&P Optica, is one of the key innovators involved in the success of the company's technology. In this Q&A, Pawluczyk introduces us to a new spectroscopy-based approach to reagent-free blood analysis that her company is in the final stages of developing. She explains how the technology works, discusses the impact it will have on the blood analysis market, and explores future applications for it in the biomedical arena.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Photonics Online? Subscribe today.

Subscribe to Photonics Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Photonics Online